Literature DB >> 2731319

Hemorrhagic shock depresses myocardial contractile function in the guinea pig.

J W Horton1.   

Abstract

Isolated coronary-perfused guinea pig hearts were used to determine if in vivo hemorrhagic shock (mean arterial blood pressure, 32.8 +/- 2.3 mmHg for 2 hr) alters intrinsic contractile function of the left ventricle. Compared to control hearts, shocked hearts developed significantly less left ventricular pressure (control: 64.7 +/- 3.3; shock: 34.1 +/- 3.1 mmHg, P less than .001) and +dP/dt max (control: 1,429 +/- 187; shock: 894 +/- 119 mmHg/sec, P less than .038) and -dP/dt max (control: 1,416 +/- 176; shock: 808 +/- 94 mmHg/sec, P less than .011) at a left ventricular end-diastolic pressure of 10 mmHg. Increasing left ventricular end-diastolic pressure from 0 to 20 mmHg, electrical pacing at control heart rate, and increased coronary flow rate failed to restore shock-induced cardiac dysfunction. Left ventricular function curves calculated from shocked hearts were shifted downward and to the right of values obtained from control hearts (P = .001). Furthermore, left ventricular performance in shocked hearts remained depressed as extracellular calcium concentration was increased from 1 to 8 mM. While calcium increased left ventricular pressure, +dP/dt max, and -dP/dt max in a dose-dependent manner in both control and shocked hearts, all indices of contractile performance were consistently less in shocked hearts than those measured in control hearts at each calcium concentration. Our data suggest that cardiac depression is a feature of hemorrhagic shock.

Entities:  

Mesh:

Year:  1989        PMID: 2731319

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  9 in total

1.  Mesenteric lymph from rats with trauma-hemorrhagic shock causes abnormal cardiac myocyte function and induces myocardial contractile dysfunction.

Authors:  Justin T Sambol; Marlon A Lee; Mingshan Jiang; Garima Dosi; Wei Dong; Edwin A Deitch; Atsuko Yatani
Journal:  J Appl Physiol (1985)       Date:  2011-06-23

2.  Cardiac function during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin-based oxygen therapeutic.

Authors:  Eilleen S Y Ao-Ieong; Alexander Williams; Vivek Jani; Pedro Cabrales
Journal:  Artif Cells Nanomed Biotechnol       Date:  2016-11-24       Impact factor: 5.678

3.  Cardiac depression and cellular injury in hemorrhagic shock and reinfusion: role of free radicals.

Authors:  R Kapoor; J Kalra; K Prasad
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Diastolic function during hemorrhagic shock in rabbits.

Authors:  Verónica D'Annunzio; Martín Donato; Andrea Fellet; Bruno Buchholz; Valeria G Antico Arciuch; María C Carreras; Laura B Valdez; Tamara Zaobornyj; Celina Morales; Alberto Boveris; Juan J Poderoso; Ana M Balaszczuk; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2011-08-13       Impact factor: 3.396

5.  Cardiac systolic function recovery after hemorrhage determines survivability during shock.

Authors:  Surapong Chatpun; Pedro Cabrales
Journal:  J Trauma       Date:  2011-04

6.  Dimethyl amiloride, a Na+-H+ exchange inhibitor, and its cardioprotective effects in hemorrhagic shock in in vivo resuscitated rats.

Authors:  Mona Soliman
Journal:  J Physiol Sci       Date:  2009-03-07       Impact factor: 2.781

7.  Left ventricular function after severe trauma.

Authors:  N Smaïl; A Descorps Declère; J Duranteau; B Vigué; K Samii
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

8.  Hemostatic properties of a venomic protein in rat organ trauma.

Authors:  Roscoe L Warner; Shannon D McClintock; Adam G Barron; Felix A de la Iglesia
Journal:  Exp Mol Pathol       Date:  2009-09-10       Impact factor: 3.362

9.  Transfusion of Anaerobically or Conventionally Stored Blood After Hemorrhagic Shock.

Authors:  Alexander T Williams; Vivek P Jani; Travis Nemkov; Alfredo Lucas; Tatsuro Yoshida; Andrew Dunham; Angelo D'Alessandro; Pedro Cabrales
Journal:  Shock       Date:  2020-03       Impact factor: 3.533

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.